Chemical space screening around Phe3 in opioid peptides: Modulating µ versus δ agonism by Suzuki-Miyaura cross-couplings.
暂无分享,去创建一个
H. V. van Vlijmen | L. Gendron | P. Schiller | B. Maes | N. N. Chung | P. Sarret | Jean-Michel Longpré | S. Ballet | Émilie Eiselt | Wim B. G. Schepens | T. Willemse | K. Hollanders | Véronique Blais | Brian J. Holleran
[1] B. Maes,et al. The Suzuki–Miyaura Cross-Coupling as a Versatile Tool for Peptide Diversification and Cyclization , 2017 .
[2] R. Turnaturi,et al. Multitarget opioid ligands in pain relief: New players in an old game. , 2016, European journal of medicinal chemistry.
[3] B. Maes,et al. Suzuki–Miyaura Diversification of Amino Acids and Dipeptides in Aqueous Media , 2015 .
[4] B. Vergani,et al. Amino acidic scaffolds bearing unnatural side chains: an old idea generates new and versatile tools for the life sciences. , 2014, Bioorganic & medicinal chemistry letters.
[5] J. Vine,et al. A high throughput screen for 17 Dermorphin peptides in equine and human urine and equine plasma. , 2014, Drug testing and analysis.
[6] Alain Wagner,et al. Developments in the field of bioorthogonal bond forming reactions-past and present trends. , 2014, Bioconjugate chemistry.
[7] G. Pasternak. Opioids and their receptors: Are we there yet? , 2014, Neuropharmacology.
[8] J. Chin,et al. Bioorthogonal reactions for labeling proteins. , 2014, ACS chemical biology.
[9] G. Lloyd‐Jones,et al. Selection of boron reagents for Suzuki-Miyaura coupling. , 2014, Chemical Society reviews.
[10] L. Feliu,et al. Solid-phase synthesis of 5-arylhistidine-containing peptides with antimicrobial activity through a microwave-assisted Suzuki-Miyaura cross-coupling , 2012 .
[11] D. Weiss,et al. Superpotent [Dmt¹] dermorphin tetrapeptides containing the 4-aminotetrahydro-2-benzazepin-3-one scaffold with mixed μ/δ opioid receptor agonistic properties. , 2011, Journal of medicinal chemistry.
[12] A. Suzuki. Cross-coupling reactions of organoboranes: an easy way to construct C-C bonds (Nobel Lecture). , 2011, Angewandte Chemie.
[13] B. G. Davis,et al. A convenient catalyst for aqueous and protein Suzuki-Miyaura cross-coupling. , 2009, Journal of the American Chemical Society.
[14] K. Constantine,et al. Eleven amino acid glucagon-like peptide-1 receptor agonists with antidiabetic activity. , 2009, Journal of medicinal chemistry.
[15] G. Valencia,et al. Arylation of Phe and Tyr side chains of unprotected peptides by a Suzuki-Miyaura reaction in water. , 2008, Organic letters.
[16] S. Ananthan. Opioid ligands with mixed μ/δ opioid receptor interactions: An emerging approach to novel analgesics , 2006, The AAPS Journal.
[17] V. Hruby,et al. Development of Novel Enkephalin Analogues that Have Enhanced Opioid Activities at Both μ and δ Opioid Receptors , 2007 .
[18] J. Svendsen,et al. Application of the Suzuki-Miyaura cross-coupling to increase antimicrobial potency generates promising novel antibacterials. , 2007, Bioorganic & medicinal chemistry letters.
[19] G. Molander,et al. Organotrifluoroborates: protected boronic acids that expand the versatility of the Suzuki coupling reaction. , 2007, Accounts of chemical research.
[20] D. Seebach,et al. Synthesis of β3‐Homophenylalanine‐Derived Amino Acids and Peptides by Suzuki Coupling in Solution and on Solid Support , 2006 .
[21] M. Francis,et al. Transition metal catalyzed methods for site-selective protein modification. , 2006, Current opinion in chemical biology.
[22] V. Hruby,et al. Synthesis and biological activity of the first cyclic biphalin analogues. , 2006, Bioorganic & medicinal chemistry letters.
[23] M. Meldal,et al. Solid-phase synthesis of biarylalanines via Suzuki cross-coupling and intramolecular N-acyliminium Pictet–Spengler reactions , 2005 .
[24] M. Waldhoer,et al. Opioid receptors. , 2004, Annual review of biochemistry.
[25] J. Nicholas,et al. Solid-phase synthesis of dual α4β1/α4β7 integrin antagonists: two scaffolds with overlapping pharmacophores , 2002 .
[26] S. Salvadori,et al. Evaluation of the Dmt-Tic pharmacophore: Conversion of a potent δ-opioid receptor antagonist into a potent δ agonist and ligands with mixed properties , 2002 .
[27] S. Kotha,et al. A new approach for modification of phenylalanine peptides by Suzuki-Miyaura coupling reaction. , 2001, Bioorganic & medicinal chemistry letters.
[28] A. Lipkowski,et al. The opioid peptide analogue biphalin induces less physical dependence than morphine. , 2001, Life sciences.
[29] Peter W. Schiller,et al. The Opioid μ Agonist/δ Antagonist DIPP-NH2[Ψ] Produces a Potent Analgesic Effect, No Physical Dependence, and Less Tolerance than Morphine in Rats , 1999 .
[30] L. Negri,et al. The dermorphin peptide family. , 1996, General pharmacology.
[31] Norio Miyaura,et al. Palladium-Catalyzed Cross-Coupling Reactions of Organoboron Compounds , 1995 .
[32] H. Mosberg,et al. Systemic analgesic activity and delta-opioid selectivity in [2,6-dimethyl-Tyr1,D-Pen2,D-Pen5]enkephalin. , 1992, Journal of medicinal chemistry.
[33] S. Udenfriend,et al. Opioid peptides : biology, chemistry, and genetics , 1984 .
[34] V. Erspamer,et al. Amino acid composition and sequence of dermorphin, a novel opiate-like peptide from the skin of Phyllomedusa sauvagei. , 2009, International journal of peptide and protein research.
[35] V. Erspamer,et al. PHARMACOLOGICAL DATA ON DERMORPHINS, A NEW CLASS OF POTENT OPIOID PEPTIDES FROM AMPHIBIAN SKIN , 1981, British journal of pharmacology.